Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eiger BioPharmaceuticals

1.73
0.0000
Volume:- -
Turnover:- -
Market Cap:2.55M
PE:-0.03
High:1.73
Open:1.73
Low:1.73
Close:1.73
Loading ...
Jun 17, 2020

Major Issues Report

8-K - Current report
May 19, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Apr 01, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 23, 2020

Major Issues Report

Current report, item 8.01
Mar 13, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 13, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 07, 2020

Major Issues Report

Current report, item 5.02
Jan 06, 2020

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Dec 26, 2019

Correspondence

[Cover]Correspondence
Dec 16, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Nov 18, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]